ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ABCL AbCellera Biologics Inc

3.67
0.04 (1.10%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
AbCellera Biologics Inc ABCL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.04 1.10% 3.67 08:23:30
始値 安値 高値 終値 前日終値
3.69 3.64 3.80 3.76 3.63
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0901:05BWAbCellera Presents Data on T-Cell Engagers Against Four..
2024/4/0405:05BWAbCellera to Report First Quarter 2024 Financial Results on..
2024/3/2005:05BWAbCellera to Present at the Bloom Burton Healthcare..
2024/3/1122:00BWAbCellera to Collaborate with Biogen to Discover Therapeutic..
2024/3/0606:30BWAbCellera Announces Four Presentations on T-Cell Engagers at..
2024/2/2804:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:49EDGAR2Form 8-K - Current report
2024/2/2406:30BWAbCellera Announces Resignation of Board Member
2024/2/2310:15BWAbCellera to Present at Upcoming Investor Conferences in..
2024/2/2106:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2106:27EDGAR2Form 8-K - Current report
2024/2/2106:05BWAbCellera Reports Full Year 2023 Business Results
2024/1/2406:05BWAbCellera to Report Full Year 2023 Financial Results on..
2024/1/1708:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1708:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1708:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1708:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:05BWAbCellera to Present at the 42nd Annual J.P. Morgan..
2023/12/2008:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2907:28EDGAR2Form 8-K - Current report
2023/11/2806:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1706:05BWAbCellera to Present at the Piper Sandler 35th Annual..
2023/11/0905:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0401:05BWAbCellera Presents New Data on Two T-Cell Engager Programs..
2023/11/0305:13EDGAR2Form 8-K - Current report
2023/11/0305:05BWAbCellera Reports Q3 2023 Business Results
2023/11/0205:05GLOBEPrelude Therapeutics and AbCellera Enter Partnership to..
2023/11/0105:05BWAbCellera to Present at the Jefferies London Healthcare..
2023/10/1205:05BWAbCellera to Report Third Quarter 2023 Financial Results on..
2023/9/2722:00BWAbCellera Announces Two T-Cell Engager Presentations at SITC..
2023/9/2106:02BWAbCellera Expands Multi-Target Antibody Discovery..
2023/9/2022:00BWAbCellera Expands Multi-Target Antibody Discovery..
2023/9/1505:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1322:00BWAbCellera Announces Collaboration with Incyte to Accelerate..
2023/8/2602:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:15EDGAR2Form 8-K - Current report
2023/8/0405:05BWAbCellera Reports Q2 2023 Business Results
2023/7/2505:05BWAbCellera Announces that the U.S. Patent Trial and Appeal..
2023/7/0705:05BWAbCellera to Report Second Quarter 2023 Financial Results on..
2023/5/3005:05BWAbCellera to Present at the Goldman Sachs 44th Annual Global..
2023/5/2502:10BWAbCellera Partners with the Governments of Canada and..
2023/5/0505:05BWAbCellera Reports Q1 2023 Business Results

最近閲覧した銘柄

Delayed Upgrade Clock